For several years, GSK was the leading pharmaceutical company in the UK based on market capitalization. However, AstraZeneca received a significant boost among the leading companies, especially ...
We tested and reviewed 15 popular tape measures by running each through a comprehensive testing program to find the best worth buying. After months of measuring various materials and shapes ...
Q. So, what are people doing when they are taping their mouths shut? A. What it entails is taking some sort of hypoallergenic strip of tape and taping one’s mouth closed and then going to sleep. A.
The global pharmaceutical market is to a large degree driven by its top pharmaceutical products. The same is true for the leading pharmaceutical companies, which generate a large share of their ...
The facility will not be used to make Ozempic and Wegovy, a spokesperson told Fierce Pharma Wednesday. Elsewhere, Novo is in line to purchase three Catalent fill-finish sites for $11 billion from ...
Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing outlay in China, marking its biggest investment in the country to date.
Kinesiology tape is a relatively new tool used in physical therapy that is not appropriate for everyone. This stretchy cotton tape is thought to ease pain and disability from sports injuries and a ...
The average monthly income at the time hovered around $220 a month, which was nowhere near the $1,000 per month the pharma companies were charging for their wares. Faced with a virus that was ...
ZURICH, Nov 26 (Reuters) - Switzerland's Roche (ROG.S), opens new tab will acquire its U.S. collaboration partner Poseida Therapeutics (PSTX.O), opens new tab in a cash deal worth up to $1.5 ...
Vista Outdoor stockholders on Monday approved Czechoslovak Group’s offer of almost $2.23bn for Kinetic. As part of a two-step break-up deal that valued Vista at $3.35bn, its sports equipment ...
including small molecules for amyotrophic lateral sclerosis (ALS), Parkinson’s disease, fibrosis, and a TGF-beta receptor type 1 inhibitor for dermatology and musculoskeletal disorders, as per ...
The acquisition is set to add Kate Therapeutics’ preclinical candidates for DMD, FSHD and DM1 to Novartis’ portfolio. Credit: © 2024 Novartis AG. Novartis has ...